Ziyang Wang
-
- Psoriasis: Treatment and Pathogenesis 4
-
- Peptidase Inhibition and Analysis 2
-
- Inflammasome and immune disorders 4
- RNA Interference and Gene Delivery 2
- Melanoma and MAPK Pathways 2
- Ubiquitin and proteasome pathways 2
-
- Pharmacological Effects of Natural Compounds 3
-
- Nanoplatforms for cancer theranostics 3
- Co-authors
- Meng LiuYan ZhengYimin CuiZhaoqian LiuNan ZhaoXiaofeng LiQiqi DuanYuhong Zheng
- Cited by
- PhysiologyImmunologyOncology
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ziyang Wang
24 papers receiving 250 citations
Peers
Comparison fields: 5 of 79
- Physiology 22
- Immunology 54
- Oncology 62
- Biological Psychiatry 5
- Cancer Research 27
Countries citing papers authored by Ziyang Wang
This map shows the geographic impact of Ziyang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziyang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziyang Wang more than expected).
Fields of papers citing papers by Ziyang Wang
This network shows the impact of papers produced by Ziyang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziyang Wang. The network helps show where Ziyang Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ziyang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 3 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 1 | |
| 8 | 2024 | 10 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 0 | |
| 11 | 2024 | 29 | |
| 12 | 2023 | 9 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 1 | |
| 15 | 2023 | 7 | |
| 16 | 2022 | 22 | |
| 17 | 2022 | 1 | |
| 18 | 2021 | 25 | |
| 19 | 2021 | 3 | |
| 20 | 2020 | 29 |
About Ziyang Wang
Ziyang Wang is a scholar working on Pharmacology, Physiology and Immunology, having authored 31 papers that have together received 264 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (4 papers), Inflammasome and immune disorders (4 papers), Pharmacological Effects of Natural Compounds (3 papers), Nanoplatforms for cancer theranostics (3 papers), RNA Interference and Gene Delivery (2 papers), Melanoma and MAPK Pathways (2 papers), Peptidase Inhibition and Analysis (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Physiology (22 citations), Immunology (54 citations) and Oncology (62 citations). Ziyang Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Meng Liu, Yan Zheng, Yimin Cui, Zhaoqian Liu, Nan Zhao, Xiaofeng Li, Qiqi Duan, Yuhong Zheng, Da Wang and Yunlong Yin. Their work appears in journals such as Nature Communications, Analytical Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.